Dr. Prada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 E Chicago Ave
Chicago, IL 60611Phone+1 312-227-4000Fax+1 513-636-7194
Summary
- Dr. Carlos Prada is a pediatrician and clinical geneticist at Lurie Children’s Hospital and Northwestern University. He also speaks multiple languages, including Spanish. He specializes in medical genetics and is experienced in neurofibromatosis, metabolic disorders, lysosomal storage diseases, newborn screening, and undiagnosed diseases.
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Medical Biochemical Genetics, 2011 - 2013- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics/Medical Genetics and Genomics, 2006 - 2011
Industrial University of Santander Faculty of MedicineClass of 2003
Certifications & Licensure
IL State Medical License 2021 - 2026
OH State Medical License 2006 - 2026
KY State Medical License 2020 - 2025
NC State Medical License 2020 - 2022- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Pediatrics Pediatrics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Annual Scholar Excellence Award Cincinnati Children´s Hospital Medical Center, 2013
- Clinical Biochemical Genetics Fellowship Award ACMG Foundation, 2012
Clinical Trials
- PKU Skin Stripping Start of enrollment: 2015 Oct 12
Publications & Presentations
PubMed
- 25 citationsPOLRMT mutations impair mitochondrial transcription causing neurological disease.Monika Oláhová, Bradley Peter, Zsolt Szilagyi, Hector Diaz-Maldonado, Meenakshi Singh
Nature Communications. 2021-02-18 - 100 citationsPediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1.Carlos E. Prada, Fatima A. Rangwala, Lisa J. Martin, Anne Lovell, Howard M. Saal
The Journal of Pediatrics. 2012-03-01 - 68 citationsThe Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants.Katrina Tatton-Brown, Anna Zachariou, Chey Loveday, Anthony Renwick, Shazia Mahamdallie
Wellcome Open Research. 2018-04-23
Press Mentions
All Illinois Newborns to Be Screened for Genetic Disorder, Thanks to Oswego FamilySeptember 3rd, 2024- The Quest by Circadian Medicine to Make the Most of Our Body ClocksJuly 6th, 2022
NF1 Patient Missense Variants Predict a Role for ATM in Modifying Neurofibroma InitiationOctober 29th, 2019
Professional Memberships
- American Society of Human GeneticsMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
